Determining equivalence and the impact of sample size in anti-infective studies: a point to consider

DOI10.1080/10543409608835146zbMath0905.62106OpenAlexW2059670592WikidataQ47328485 ScholiaQ47328485MaRDI QIDQ4216000

David R. Bristol

Publication date: 3 February 1999

Published in: Journal of Biopharmaceutical Statistics (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.1080/10543409608835146

zbMATH Keywords

equivalencesample sizebinomialconfidence limitanti-infectives

Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10)

Related Items (3)

Testing general hypotheses under binomial sampling: the two sample case-asymptotic theory and exact procedures ⋮ On the use of the ratio or the odds ratio of cure rates in therapeutic equivalence clinical trials with binary endpoints ⋮ CLINICAL EQUIVALENCE

Cites Work

• Planning and Monitoring of Equivalence Studies

This page was built for publication: Determining equivalence and the impact of sample size in anti-infective studies: a point to consider